Autopsy report · NCT02150447

The Use of Proton Pump Inhibitor on the Prevention of Gastric Cancer Bleeding

“Low enroll rate”

The sponsor’s own words in the registry.

Life of this trial

• Registered 4 years 11 months after it had already started.
• Ran for about 7 years 11 months before it stopped.
• 394 participants planned (an estimate, not an actual count).
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 3

Sponsor

National Cancer Center, Korea

Sponsor type

Government (non-US federal)

Conditions

Gastric Cancer; Bleeding

Interventions

Proton pump inhibitor; Placebo

Participants

394 (planned, not actual)

Sites

4

Countries

South Korea

Trials that died the same way

• An Interventional, Confirmative, Post Marketing Clinical Followup (PMCF) Study to Evaluate Performance and Safety of Ophthalmic Solutions Used to Relieve Dry Eyes Like Symptoms in Glaucoma Patients.
  “Low enrollment rate” (90% match in meaning)
• Targeted Pharmacological and Behavioral Treatments for Smoking in Schizophrenia Study 1
  “Low rate of enrollment” (87% match in meaning)
• Trial of Supplemental Parenteral Nutrition in Under and Over Weight Critically Ill Patients (TOP-UP)
  “Low enrollment rates.” (81% match in meaning)
• Effect of Holofiber Socks and Bedding on Pain and Quality of Sleep in Subjects With Chronic Foot Pain
  “Low enrollment” (80% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.